Citation: | WANG Yuxin, GUO Xiaoxiao, YANG Deyan, ZHAO Jiuliang, JIANG Ying, HU Rongrong, SHEN Dongchao, MAO Yueying, WANG Lin, YAN Xiaowei. Coronary Aneurysm-like Dilation with Stenosis, Anti-phospholipid Antibody Syndrome, Nephrotic Syndrome, and Polycystic Kidney: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1069-1073. DOI: 10.12290/xhyxzz.2021-0678 |
[1] |
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)[J]. J Thromb Haemost, 2006, 4: 295-306. DOI: 10.1111/j.1538-7836.2006.01753.x
|
[2] |
Meroni PL, Raschi E, Testoni C, et al. Antiphospholipid antibodies and the endothelium[J]. Rheum Dis Clin North Am, 2001, 27: 587-602. DOI: 10.1016/S0889-857X(05)70222-2
|
[3] |
Pyo R, Lee JK, Shipley JM, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms[J]. J Clin Invest, 2000, 105: 1641-1649. DOI: 10.1172/JCI8931
|
[4] |
de Carvalho JF, Shoenfeld Y. Aneurysms in primary antiphospholipid syndrome: a case-based review[J]. Clin Rheumatol, 2021, 40: 3001-3006. DOI: 10.1007/s10067-020-05564-9
|
[5] |
Gracia-Tello B, Isenberg D. Kidney disease in primary anti-phospholipid antibody syndrome[J]. Rheumatology, 2017, 56: 1069-1080.
|
[6] |
Bienaimé F, Legendre C, Terzi F, et al. Antiphospholipid syndrome and kidney disease[J]. Kidney Int, 2017, 91: 34-44. DOI: 10.1016/j.kint.2016.06.026
|
[7] |
Nochy D, Daugas E, Droz D, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome[J]. J Am Soc Nephrol, 1999, 10: 507-518. DOI: 10.1681/ASN.V103507
|
[8] |
Ohara K, Kimura T, Karasawa T, et al. A large coronary aneurysm and its probable precursor lesions in a patient with autosomal dominant polycystic kidney disease: an implication for the process of aneurysmogenesis[J]. Pathol Int, 2012, 62: 758-762. DOI: 10.1111/pin.12007
|
[9] |
Neves JB, Rodrigues FB, Lopes JA. Autosomal dominant polycystic kidney disease and coronary artery dissection or aneurysm: a systematic review[J]. Ren Fail, 2016, 38: 493-502. DOI: 10.3109/0886022X.2016.1144209
|
[10] |
Visciano B, Di Pietro RA, Rossano R, et al. Nephrotic syndrome and autosomal dominant polycystic kidney disease[J]. Clin Kidney J, 2012, 5: 508-511. DOI: 10.1093/ckj/sfs147
|
[11] |
Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus[J]. Arthritis Rheumatol, 2019, 71: 1400-1412. DOI: 10.1002/art.40930
|